Robeco Institutional Asset Management B.V.
Position in GILD — Gilead Sciences, Inc.
CIK 1418773
ROTTERDAM, P7
Position in GILD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$437,122,881
-$30,379,010 QoQ
Shares Held
3,459,893
+3.1% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#47
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. GILD ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $437,122,881 | 3,459,893 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $467,501,891 | 3,354,394 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $453,352,709 | 3,693,602 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $422,016,561 | 3,801,951 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $414,948,270 | 3,742,656 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $372,613,198 | 3,325,419 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $316,217,795 | 3,423,382 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $287,496,414 | 3,429,108 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $239,244,648 | 3,487,023 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $262,461,342 | 3,583,090 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $291,587,961 | 3,599,407 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $280,612,530 | 3,744,496 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $297,164,964 | 3,855,780 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $320,618,813 | 3,864,274 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $314,916,944 | 3,668,223 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $224,603,419 | 3,640,840 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $222,600,741 | 3,601,371 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $220,139,247 | 3,702,931 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $255,959,834 | 3,525,132 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $139,492,615 | 1,997,031 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $146,155,694 | 2,122,505 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $132,285,524 | 2,046,813 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $120,860,195 | 2,074,497 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $126,391,311 | 2,000,179 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $109,387,521 | 1,421,725 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $94,902,960 | 1,269,435 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||